Back to catalogue
№ 124 23 filings · 2021-08-11 → 2026-03-23

GOODWIN PLC

GDWN
Industrial Goods and Services Market cap £1.1bn Overall fit 410 /1000

High-quality industrial with strong operating leverage, fair valuation and fortress balance sheet, but essentially no AI-receiver exposure — the dominant strategy pillar — pulls this into the partial-fit band despite good fundamentals.

Fair value range 10,500p–13,500p Mid case · £901m
Absolute upside -20.7% vs current market cap
Conviction 4/5 confidence in fair call
Supports the call
  • Clean accounting and explicit FY26 PBT guidance >£71m
  • Near-net-cash balance sheet limits financial risk
  • Multiple valuation approaches converge around current price
Limits the call
  • FY26 earnings step-change is partly order-timing driven, sustainability uncertain
  • Recent tender losses and Feb-2026 order-book dip introduce H2 risk
Methodology

Forward P/E (15-19x) on FY26E EPS, cross-checked vs EV/EBITDA

In one line · bull case

Quality UK industrial with multi-year defence/nuclear backlog delivering doubled profits via high operating leverage on a fortress balance sheet, but available at a fair-not-cheap price.

In one line · biggest risk

FY26 earnings spike may prove peakish if Middle East LNG dispatch delays persist and recent tender losses compound into FY27.

Drivers
AI beneficiary 18 /100
Defence/nuclear/LNG/jewellery casting — no AI revenue line and no AI-driven margin uplift in filings.
Operating leverage 78 /100
H1 FY26 revenue +27% drove trading profit +118%; foundry has stated spare capacity and rising margins.
Earnings vs expectations 72 /100
October 2025 upgrade to >£71m PBT confirmed in December H1 result; only modest offset from tender losses in March 2026.
Growth momentum 86 /100
Revenue accelerating, trading profit doubling FY26, multi-year defence and nuclear visibility.
Moat 62 /100
Vertical integration, patented polyimide and AVD, long defence/nuclear qualification cycles and Northrop exclusivity.
Earnings quality 76 /100
Strong cash conversion, transparent non-cash swap adjustment, conservative revenue recognition.
Management quality 72 /100
Family-led, long-term oriented, conservative capital allocation; minor demerit for Nov-2025 family placing.
Cyclicality 60 /100
Defence/nuclear defensive ballast offset by LNG, mining, jewellery and naval cycles.
Leverage 18 /100
Net debt £5.8m pre-special-dividend, £30m fixed sub-1% to 2031.

Goodwin PLC (GDWN) — Investment research note

Executive summary

Goodwin PLC is a family-controlled UK specialist engineering group operating through a Mechanical Engineering Division (high-integrity castings, machining, axial check valves for LNG, submersible pumps, radar systems) and a Refractory Engineering Division (investment casting powders for jewellery, vermiculite-based AVD lithium-battery extinguishers, Soluform concrete bags). The group has transformed itself over five years from an oil-and-gas-exposed foundry into a defence, nuclear-waste, LNG and naval propulsion supplier, with H1 FY26 trading profit of £37.2m more than doubling on revenue up 27% 2025-12 half-year. The single most important point for valuation today is that this is a quality industrial with exceptional operating leverage that has just delivered a step-change in earnings — but it is a defence/nuclear/LNG cycle story, not an AI story.

Fair value estimate

Methodology: Multiple of FY26E earnings, cross-checked against EV/EBITDA.

Key assumptions:

  • FY26E trading PBT > £71m (management-guided, "high degree of confidence") 2025-10 trading update
  • Tax rate ~25%, NCI ~£1.6m → attributable profit ~£51m → EPS ~680p
  • Sustainable FY27 trading PBT range: £65–80m (assumes Middle East LNG delays partially offset by Northrop programme ramp; reflects tender losses noted in 2026-03)
  • Applied 15–19x forward P/E (a fair range for a UK quality industrial with high backlog visibility, net-cash balance sheet, but cyclical end-markets)

Fair value range: 10,500p – 13,500p per share (£789m – £1,014m market cap) Mid-point: ~12,000p / £901m

Versus current £865.1m market cap (≈11,520p/share): ~4% upside to mid-point, range −9% to +17%. Verdict: fairly valued.

Sector context

Confirmed ICB classification: Industrial Goods and Services. Goodwin sits as a higher-quality, higher-growth, lower-leverage outlier vs. typical UK industrials — net cash before the special dividend, no dilutive M&A, family stewardship. Comparable listed UK specialty engineering peers include Avingtrans (AVG) (nuclear/aerospace), Renew Holdings (RNWH) (infrastructure services), and to a lesser extent Rotork (ROR) (flow control). Margin profile (27% trading margin in H1 FY26) is materially above the UK industrial peer median.

Investment thesis

  1. Multi-year defence and nuclear backlog with visible ramp: Sellafield 63-element rack framework now at 100 units contracted (27 delivered), MoU with Northrop Grumman covering four programmes with $16m initial and potential $200m order pipeline, exclusivity on a critical patented component (25–30% of MoU value, eligible for UK patent box) 2025-09 trading update. The US Government has funded $14.5m of radiography capacity at Goodwin Steel Castings, increasing throughput 300% 2024-09 trading update.

  2. Demonstrated operating leverage at scale: H1 FY26 revenue +27%, gross margin 49.3% vs 43.0%, trading margin 27.4% vs 16.1%, trading profit +118% 2025-12 half-year. Mechanical segment operating profit doubled (£30.8m vs £13.8m). Order book at £365m in October 2025 (24% higher than April 2025) underpins full-year guidance of trading PBT >£71m, double the prior year 2025-10 trading update.

  3. Fortress balance sheet returning capital: Net debt only £5.8m at end-October 2025 (vs £38.8m a year earlier), £30m of debt fixed at <1% to 2031. The board declared a 532p special interim dividend (£40m) on top of ordinary distributions — funded organically 2025-10 trading update, 2025-12 half-year.

Key risks

  1. Order timing and tender losses: March 2026 update flagged two material tender losses (€18m Estonian radar at Easat, £45m+ Sellafield bid at Goodwin International) and Middle East LNG dispatch delays — order book has dropped from £365m (Oct 2025) to £288m (Feb 2026) 2026-03 trading update. The FY26 earnings spike may be partially front-loaded.

  2. End-market cyclicality: Refractory's jewellery casting demand is consumer-sensitive (Feb 2026 noted gold/silver prices weighing on confidence). Mining capex (pumps) and LNG capex are cyclical. Naval/nuclear is the defensive ballast, but not large enough alone to sustain current earnings level 2026-03 trading update.

  3. Family control / governance optics: Goodwin family placed 1.6% of shares in November 2025 via Rothschild & Co Redburn just weeks after declaring the special dividend 2025-11 placing. This is small and locked-up 180 days, but is a signal worth watching alongside the FY26 earnings peak. Capital allocation also leans toward dividends rather than buybacks/M&A, which is a constraint on compounding.

Operating leverage

This is genuinely a high-operating-leverage business at the current activity level. The fixed-cost base — Stoke-on-Trent foundry, machine shops, Hoben calciners, Duvelco polyimide plant — is largely unchanged regardless of throughput, so incremental revenue drops disproportionately to profit. The evidence is in the H1 FY26 result: revenue +27%, trading profit +118%, with administrative expenses up just 7.5% (£23.7m vs £22.0m) and selling costs broadly flat 2025-12 half-year. Segmental data shows Mechanical operating margin jumped from 18.6% to 30.1% in H1 on a ~38% revenue lift, while Refractory margin was steadier (25.9% vs 20.9%). Capacity-wise the US-funded radiography upgrade increases foundry throughput 300% at component level 2024-09 trading update, and management notes the foundry "still has capacity to take on additional contracts" 2025-03 trading update. A further 10–20% revenue beat above current FY26 expectations would plausibly add 30–50% to operating profit — meaningful, though now off a higher base. Duvelco polyimide is an unquantified call option: substantial fixed cost already absorbed, zero revenue to date, first material contribution not expected until FY28+ 2026-03 trading update.

Value-trap signals

None identified. Revenue trajectory is positive, debt is low, no dividend cuts (special dividend instead), no related-party concerns disclosed, no regulatory threats, growing end-markets in defence/nuclear. The recent tender losses are a watch-item but do not constitute a value-trap signal.

Earnings vs expectations

Goodwin's policy is not to provide forward guidance, so consensus comparisons are limited. Where references exist: the September 2024 trading update commented Easat profit "now coming to fruition" after years of slippage (a delayed beat). The October 2025 update materially upgraded full-year expectations to >£71m PBT (vs £35.5m prior) 2025-10 trading update, and the December 2025 H1 result was consistent with that. The March 2026 update confirmed in-line trading vs October expectations despite tender losses. Pattern: operationally consistent delivery with positive surprises in the past 18 months as the defence/nuclear ramp materialised; structurally low disclosure makes consensus tracking difficult.

Conviction

Conviction: 4 (high).

Anchors: (i) clean, well-disclosed accounts with conservative reporting (interest-rate-swap adjustments shown transparently); (ii) management-quantified FY26 PBT guidance of >£71m and a near-net-cash balance sheet leave little room for hidden gearing; (iii) multiple valuation approaches (forward P/E ~17x, EV/EBITDA mid-single-digit) converge.

Caveats: (i) the FY26 step-change in profit is partly cycle/order-timing driven (LNG ramp, Sellafield ramp), so the right "through-cycle" multiple is debatable; (ii) the March 2026 order-book dip and tender losses raise the question of whether £71m is the new run-rate or a peak.


Driver scoring

  • ai_beneficiary: 18 — Not an AI play. Defence/nuclear/LNG/jewellery casting/mining are the drivers. Very loose tangential link via nuclear power for data-centre baseload, but no AI revenue line, no AI-driven margin expansion.
  • operating_leverage: 78 — Demonstrated in H1 FY26: revenue +27% drove trading profit +118%. High fixed-cost foundry/machine-shop base, capacity headroom flagged by management, gross margin expansion from 43% to 49% on volume.
  • earnings_surprise_trend: 72 — Materially upgraded expectations in October 2025; consistent delivery against revised guidance; long-promised Easat turnaround now beginning. Tender losses in March 2026 a modest offset.
  • cyclicality: 60 — Defence/nuclear segments are defensive; LNG, mining pumps, jewellery casting and naval shipbuilding cycles introduce moderate cyclicality. Capital-goods order book lumpiness adds variance.
  • moat: 62 — Vertical integration (own foundry feeding own valves/pumps), patent-pending Duvelco polyimide, patent-protected AVD, long defence/nuclear approval cycles create high switching costs. Northrop "exclusivity" on a critical component and 14 years of apprentice school build skill barriers.
  • leverage: 18 — Net debt £5.8m at Oct 2025, jumping to £53m post-special-dividend (still ~0.6x EBITDA). £30m fixed at <1% to 2031. Fortress balance sheet.
  • earnings_quality: 76 — Strong cash conversion (operating cash flow £27m H1 FY26), non-cash interest-rate-swap adjustments transparently reconciled, conservative revenue recognition on long-term contracts, contract liabilities (advance payments) of £57m provide working-capital cushion.
  • management_quality: 72 — Family-controlled with long-term orientation, conservative capital allocation, transparent disclosure of segment economics, training school producing internal talent. Light marks for relatively limited buyback history and minor family share placing in Nov 2025.
  • growth_momentum: 86 — Revenue accelerating (£131m FY21 → £220m FY25 → ~£270m+ FY26E), trading profit doubling FY26, multi-year order book visibility in defence and nuclear.

overall_score: 410

Rationale: This is a genuinely high-quality industrial with a fortress balance sheet, exceptional operating leverage, demonstrated execution, and a fair valuation — it would fit a generalist quality-compounder portfolio well. But against this investor's specific AI-receiver mandate it scores in the "partial fit" band: the operating-leverage and valuation pillars are strong, but the AI-receiver pillar — weighted ~35% — is essentially absent. The ~10% upside to mid-point fair value is fair-not-cheap. A name to know about and potentially buy on weakness, but not a focus position for an AI-receiver strategy.

Filings consulted · 24

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-03-23Trading Update2026-03-23_9486732_trading-update.md0.85
  2. 2025-12-16Half Year Report2025-12-16_9298605_half-year-report.md0.90
  3. 2025-11-14Placing OF Shares IN Goodwin Plc2025-11-14_9232984_placing-of-shares-in-goodwin-plc.md0.70
  4. 2025-10-27Trading Update2025-10-27_9195045_trading-update.md0.72
  5. 2025-10-01Result OF Agm2025-10-01_9144443_result-of-agm.md0.26
  6. 2025-09-24Trading Update Amp Strategic Collaboration Agreement2025-09-24_9128296_trading-update-amp-strategic-collaboration-agreement.md0.72
  7. 2025-08-14Posting OF Annual Report And Accounts2025-08-14_9053479_posting-of-annual-report-and-accounts.md0.81
  8. 2025-03-19March 2025 Trading Update2025-03-19_8786512_march-2025-trading-update.md0.55
  9. 2024-12-17Half Year Report2024-12-17_8614849_half-year-report.md0.58
  10. 2024-10-02Result OF Agm2024-10-02_8457940_result-of-agm.md0.20
  11. 2024-09-25September 2024 Trading Update2024-09-25_8438668_september-2024-trading-update.md0.55
  12. 2024-08-22Posting OF Annual Report And Accounts2024-08-22_8380738_posting-of-annual-report-and-accounts.md0.62
  13. 2024-03-14March 2024 Trading Update2024-03-14_8086784_march-2024-trading-update.md0.38
  14. 2023-12-20Half Year Report2023-12-20_7952672_half-year-report.md0.41
  15. 2023-09-29Result OF Agm2023-09-29_7787345_result-of-agm.md0.14
  16. 2023-08-29Posting OF Annual Report And Accounts2023-08-29_7723250_posting-of-annual-report-and-accounts.md0.43
  17. 2022-12-20Half Year Report2022-12-20_7184423_half-year-report.md0.23
  18. 2022-10-05Result OF Agm2022-10-05_7247842_result-of-agm.md0.07
  19. 2022-08-19Posting OF Annual Report And Accounts2022-08-19_7186852_posting-of-annual-report-and-accounts.md0.24
  20. 2022-08-03Final Results2022-08-03_6958940_final-results.md0.25
  21. 2021-12-15Half Year Report2021-12-15_6831923_half-year-report.md0.23
  22. 2021-10-06Result OF Agm2021-10-06_6712700_result-of-agm.md0.07
  23. 2021-08-31Posting OF Annual Report And Accounts2021-08-31_6694241_posting-of-annual-report-and-accounts.md0.24
  24. 2021-08-11Final Results2021-08-11_6499414_final-results.md0.25

This research note was authored by a large language model after reading 23 regulatory filings published between 2021-08-11 and 2026-03-23. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.